Drugs Made In America Acquisition Units Current Assets

As of the most recent data (June 2026), DMAAU shows a current assets of $69K. That compares with $50K in the prior-year period — up 39.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAAU's current assets is now $69K (was $50K) — a 39.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Drugs Made In America Acquisition Units is outperforming or lagging.

Tracking DMAAU's current assets over time shows whether Drugs Made In America Acquisition Units is scaling, shrinking, or reshaping that part of the business. The current reading is $69K That compares with $50K in the prior-year period — up 39.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Drugs Made In America Acquisition Units's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $69K) with ownership activity and broader fundamentals.